Incidence Rates [28] | HCA-CDI rate per 100,000 persons | Recurrence Rate Per 100,000 persons | Death Rate Per 100,000 persons |
---|---|---|---|
Age Group | |||
1–17 | 6.3 | 0.4 | NA |
18–44 | 18.3 | 3.0 | NA |
45–64 | 83.1 | 10.9 | 5.4 |
≥ 65 | 481.5 | 117.6 | 55.1 |
Effectiveness of the Multifaceted CDI Intervention [27] | 10 and 50% | ||
35 and 50% | |||
Cost Inputs [27] | Cost Per Hospital Discharge | ||
Infection Control and Isolation Costs | $3.56 (50 effectiveness), –6.41 (10% effectiveness) | ||
Implementation of the Antimicrobial Use (AU) module | |||
Initial Cost (in 2015) | $0.08 | ||
Ongoing Costs | $0.03 | ||
Antibiotic Stewardship Personnela | |||
(1.2 Pharmacists +0.67 Infectious Disease Physician + 0.05 Network Data Analysis) × 0.25 | $20.58 | ||
Federal Government Investment | |||
Initial Cost (2009–2014) | $0.18 | ||
Ongoing Costs (2015) | $0.03 | ||
Cost of Enhanced Cleaning | $0.28 | ||
Total | |||
Initial cost (2015) | |||
50% program effectiveness | $24.68 | ||
10% program effectiveness | $27.52 | ||
On-going cost (2016–2020) | |||
50% program effectiveness | $24.47 | ||
10% program effectiveness | $27.32 | ||
Benefits of Prevention | |||
Attributable Patient Cost Savings | |||
HCA-CDI [27] | $ 6844 (Per Prevented Case) | ||
Recurrent CDI [27] | $12,703 (Per Prevented Case) | ||
Length Of Hospital Stay (LOS)b | |||
Mild/Moderate HCA-CDI Disease | 9.5 days | ||
Recurrent Disease | 8.8 days | ||
QALY/ adjusted to QALD by LOSc | |||
Mild/Moderate HCA-CDI Disease | 0.80 / 0.005205479 | ||
Recurrent Disease | 0.708 / 0.00704 |